Quick answer
The scientific evidence behind stem cell therapy varies significantly by indication. Some conditions, such as leukaemia, have bone-marrow transplantation as a long-established standard of care, while use for anti-aging or cosmetic purposes has more limited human research. Cheongdam Cell Clinic describes general stem cell properties consistent with current academic understanding, but consumers should distinguish between well-accepted biological mechanisms and specific outcomes that still require further evidence.
When discussing 'scientific evidence' in medicine, researchers typically rank evidence reliability in a hierarchy, from expert opinion and single case reports through animal studies up to randomized controlled trials, considered the gold standard. Understanding this hierarchy helps consumers judge how much weight to give any particular claim.
The strongest evidence base for stem cell use in medicine is hematopoietic stem cell transplantation for blood cancers such as leukaemia and certain lymphomas — a decades-old standard treatment backed by extensive study data. This is clearly distinct from using MSCs for cosmetic or anti-aging purposes.
For MSC use in tissue repair, knee osteoarthritis, or vascular improvement, a number of clinical studies show promising results, particularly for osteoarthritis and critical limb ischaemia. However, many of these studies have small sample sizes, short follow-up periods, or lack proper control groups, meaning firm population-wide conclusions cannot yet be drawn.
By contrast, stem cell use for general cosmetic purposes, such as skin rejuvenation or hair-loss treatment, or for holistic anti-aging, has relatively few systematic human clinical studies compared with other medical indications. Most available evidence comes from small studies or clinic-reported outcomes, which carry significantly less reliability than randomized controlled trials.
Cheongdam Cell Clinic describes general stem cell properties, such as vascular regeneration and immune support, that align with mechanisms accepted to some degree in academic circles. However, consumers should distinguish accepted biological mechanisms from any guarantee of a specific outcome for an individual patient, which still depends on many personal factors and is not backed by publicly disclosed statistical data from the clinic.
Another key limitation is the wide variability in methodology across clinics worldwide — cell source (bone marrow, fat, or umbilical cord), collection and processing methods, cell dosage, and injection technique. These differences mean results from one clinic's study cannot be directly generalised to another, even when both use the term 'stem cell therapy'.
For consumers considering treatment, a practical recommendation is to ask the clinic for research references specific to the indication of interest, not just general information about stem cells. Ask whether the programme has long-term follow-up data, and be cautious of broad marketing claims such as 'treats everything' or 'guaranteed results', which are inconsistent with the current state of scientific evidence.
In summary, stem cell therapy is a field with real potential and strong evidence for certain indications, but evidence remains limited for others, particularly general cosmetic and anti-aging use. Careful decision-making should rely on direct, honest questioning of the provider combined with the basic scientific understanding presented throughout this series, rather than on expectations or marketing alone.
Last updated: 2026-08-28 · This content is for information only and is not medical advice. Consult a qualified doctor before making treatment decisions.
